About Us

Coastal Plains Network, LLC, an Accountable Care Organization (ACO), is a separate legal entity formed by Vidant Health in order to participate in the Medicare Shared Savings Program (MSSP). The providers participating in the Coastal Plains Network Medicare ACO include Vidant Medical Group (ACO Professionals), Vidant Health’s eight hospitals (Hospitals and Critical Access Hospitals) and the East Carolina University Physician Plan (ACO professionals).

ACO Participants

  • Vidant Medical Group, LLC
  • East Carolina University
    • DBA East Carolina University Physician Plan
  • ECU Physicians Diagnostic Pathology Services
    • DBA East Carolina University Physician Plan
  • Duplin General Hospital, Inc.
    • DBA Vidant Duplin Hospital, Kenansville
  • East Carolina Health
    • DBA Vidant Roanoke-Chowan Hospital, Ahoskie
  • East Carolina Health-Beaufort, Inc
    • DBA Vidant Beaufort Hospital, Washington
  • East Carolina Health-Bertie
    • DBA Vidant Bertie Hospital, Windsor
  • East Carolina Health-Chowan, Inc.
    • DBA Vidant Chowan Hospital, Edenton
  • East Carolina Health-Heritage, Inc.
    • DBA Vidant Edgecombe Hospital, Tarboro
  • Pitt County Memorial Hospital, Inc.
    • DBA Vidant Medical Center, Greenville
  • The Outer Banks Hospital, Inc.
    • Jointly owned with Chesapeake Regional Healthcare, Nags Head

ACO participants in a joint venture between professionals and hospitals:

  • Outer Banks Professional Services, LLC

Contact

Coastal Plains Network, LLC 800 W.H. Smith Blvd
PO Box 6028
Greenville, NC 27835

Craig Hepp
Craig.Hepp@VidantHealth.com
252-816-0899

Hours of Operation

Monday - Friday
8:30am - 4:30pm

Disclosures

Public Disclosure
Vidant ACO Participation Waiver Public Disclosure

ACO Governing Body and Committees

ACO Governing Board

M. Suzanne Kraemer, M.D., Voting Member and Chair - ACO Participant ECUP
Tracy Eskra, M.D., Voting Member - ACO Participant VMG/VMC
Jason Foltz, M.D., Voting Member - ACO Participant ECUP
Frederick Teixeira, M.D., Voting Member - ACO Participant VMG/Beaufort Hospital
Betsy Tuttle-Newhall, M.D., Voting Member - ACO Participant ECUP
Joseph Pye, M.D., Voting Member - ACO Participant VMG
Jonathon Firnhaber, M.D., Voting Member - ACO Participant ECUP
Mott Blair, M.D., Voting Member - ACO Participant VMG/Duplin Hospital
Ted Delbridge, M.D., Voting Member - ACO Participant ECUP
Brookes Peters, M.D., Voting Member - ACO Participant VMG/Edgecombe Hospital
Scott Avery, M.D., Voting Member - Community Member
David Galloway, Voting Member - Medicare Beneficiary Representative

Key Clinical and Administrative Leadership

ACO Executive: Craig Hepp
Medical Director: M. Suzanne Kramer, MD
Compliance Official: Jeff Wiggins
Quality Assurance/Improvement Officer: Joan Wynn

Quality and Safety Committee

Joseph Pye, MD - Chair
Jason Foltz, MD
Betsy Tuttle-Newhall, MD
Steve Powell, MD
M. Suzanne Kraemer, MD

Finance Committee

Tracy Eskra, MD - Chair
Mott Blair, MD
Scott Avery, MD
Frederick Teixeira, MD
David Galloway
Ted Delbridge, MD

Compliance & Credentials Committee

David Michael, MD - Chair
Brookes Peters, MD
M. Suzanne Kraemer, MD
Jonathon Firnhaber, MD

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Partnerships or joint venture arrangements between hospitals and ACO professionals
  • Hospital Employing ACO professionals
  • Critical Access Hospital (CAH) billing under Method II

Shared Savings/Losses

Amount of Shared Savings/Losses

Agreement period beginning 2015, Performance Year 2015: $3,279,327

Agreement period beginning 2015, Performance Year 2016: $0

Shared Savings Distribution

  • Agreement period beginning 2015, Performance Year 2015
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 90%
      • 70% to ACO Providers
      • 20% to ACO Hospitals
  • Agreement period beginning 2015, Performance Year 2016
    • Proportion invested in infrastructure: 40%
    • Proportion invested in redesigned care processes/resources: 0%
    • Proportion of distribution to ACO participants: 60%
      • 45% to ACO Providers
      • 15% to ACO Hospitals

Payment Rule Waivers:

Coastal Plains ACO does not utilize the SNF 3-Day Rule Waiver


Quality Performance Results

    2015 Reporting Period
Measure # Measure Name ACO Performance Rate Mean Performance Rate (SSP ACOs)
ACO-1 CAHPS: Getting Timely Care, Appointments, and Information 76.45 80.61
ACO-2 CAHPS: How Well Your Providers Communicate 92.96 92.65
ACO-3 CAHPS: Patients’ Rating of Provider 91.22 91.94
ACO-4 CAHPS: Access to Specialists 83.74 83.61
ACO-5 CAHPS: Health Promotion and Education 61.22 59.06
ACO-6 CAHPS: Shared Decision Making 76.97 75.17
ACO-7 CAHPS: Health Status/Functional Status 73.36 72.30
ACO-34 CAHPS: Stewardship of Patient Resources* 37.16 26.87
ACO-8 Risk Standardized, All Condition Readmissions 14.95 14.86
ACO-35 Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)* 19.37 18.07
ACO-36 All-Cause Unplanned Admissions for Patients with Diabetes* 54.21 54.60
ACO-37 All-Cause Unplanned Admissions for Patients with Heart Failure 76.16 76.96
ACO-38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 66.35 62.92
ACO-9 Ambulatory Sensitive ConditionAdmissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5 1.16 1.11
ACO-10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 0.92 1.04
ACO-11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 100.00% 80.14%
ACO-39 Documentation of Current Medications in the Medical Record* 95.10% 84.07%
ACO-13 Falls: Screening for Future Fall Risk 33.33% 56.46%
ACO-14 Preventive Care and Screening: Influenza Immunization 49.35% 62.03%
ACO-15 Pneumonia Vaccination Status for Older Adults 49.60% 63.73%
ACO-16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 62.45% 71.15%
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 97.17% 90.16%
ACO-18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 43.55% 45.25%
ACO-19 Colorectal Cancer Screening 53.78% 60.06%
ACO-20 Breast Cancer Screening 66.02% 65.67%
ACO-21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 75.38% 70.04%
ACO-40 Depression Remission at Twelve Months* N/A N/A
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control (>9%) 18.73% 20.38%
ACO-41 Diabetes: Eye Exam* 38.65% 41.05%
ACO-28 Hypertension: Controlling High Blood Pressure (<140/90) 57.26% 69.62%
ACO-30 Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic 85.40% 83.82%
ACO-31 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 87.50% 87.22%
ACO-33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 78.86% 77.73%
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.*= Measure required beginning Reporting Year 2015.N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A